Neuronetics Reports Second Quarter 2026 Financial and Operating Results
Bullish within 3–6 months as Greenbrook-driven revenue growth and profitability trajectory materialize.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Bullish within 3–6 months as Greenbrook-driven revenue growth and profitability trajectory materialize.
What happened and why it matters
Neuronetics posted a solid Q2 2026, led by Greenbrook’s revenue growth and improved gross margins, signaling a path toward profitability. Management also added CFO Nir Naor and other leadership to accelerate execution, even as cash burn remains a near-term headwind. The 2026 guidance underscores growth potential but keeps cash outflow in focus.
Solid Q2 outperformance on Greenbrook, margin expansion, and a clear profitability trajectory support a near-term stock re-rating, especially as the Go-To-Market improvements are evidenced; however, the sustained cash burn remains a hurdle that could cap upside absent cash-flow improvement.
Q2 2026 total revenue: $41.6M; Greenbrook revenue $26.9M, up 16.8% YoY.
Gross margin rose to 51.1% from 46.6%, aided by new go-to-market and ARCM.
Net loss narrowed to $3.4M; Adjusted EBITDA positive at $0.3M.
Cash burn improved: net cash used in ops and investing $1.4M in Q2.
Full-year 2026 guidance: revenue $160–$164M; gross margin 48–50%; negative cash flow.
Earnings. The release centers on quarterly results, segment performance, leadership changes, and full-year guidance, all typical of an earnings category update.
More AI-analyzed coverage connected to this story